Abstract
During major liver resection, ischemia reperfusion injury occurs resulting in adverse outcome. Animal studies have demonstrated the beneficial effect of statins on hepatic ischemic injury, but no clinical studies have been performed. Twenty consecutive patients undergoing major hepatic resection were included and were randomized into two groups. The study group (n = 10) patients received oral atorvastatin 40 mg for 3 days prior to surgery, including the day of surgery, and the control group (n = 10) received a placebo. Outcomes were assessed at 4, 24, and 72 h by measurement of serum liver enzymes and cytokines—IL-1, IL-6, CRP, and TNF α. The two groups were evenly matched for demographic and perioperative variables. The AST levels were significantly higher in the control group compared with the study group at 4 h (909.60 ± 222 vs. 362.6 ± 129 U/L), 24 h (215.30 ± 86.9 vs. 605.30 ± 186.1 U/L) and 72 h (84.30 ± 32.7 vs. 204.70 ± 67.5) (p < 0.001). Plasma IL-1 values in the study group showed significantly lower values compared with the control group (p < 0.001) postoperatively. Plasma IL-6 values postoperatively showed significantly lower mean values as compared with the mean of the control population (p < 0.001). TNF α values at 4, 24, and 72 h postoperatively comparable in the two groups (p = 0.011) (p = 0.096) and (p = 0.237), respectively. Statins have the potential for pharmacological prevention of IRI. Further studies would be needed to substantiate the role of statins in prevention of IRI during liver resection.
Clinical Trial Registration: PGIMER, Chandigarh—NK/1081/MS/12182-83
Similar content being viewed by others
References
Fondevila C, Busuttil RW, Kupiec-Weglinski JW (2003) Hepatic ischemia/reperfusion injury—a fresh look. Exp Mol Pathol 74(2):86–93
Clavien PA, Harvey PR, Strasberg SM (1992) Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 53(5):957–978
Ploeg RJ, D’Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM et al (1993) Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation 55(4):807–813
Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K (1992) Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 16(2):454–461
Koneru B, Fisher A, He Y, Klein KM, Skurnick J, Wilson DJ et al (2005) Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl 11(2):196–202
Rahbari NN, Wente MN, Schemmer P, Diener MK, Hoffmann K, Motschall E et al (2008) Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg 95(4):424–432
Jegatheeswaran S, Siriwardena AK (2011) Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. HPB Oxf 13(2):71–78
Richardson AJ, Laurence JM, Lam VW (2014) Use of pre-operative steroids in liver resection: a systematic review and meta-analysis. HPB Oxf 16(1):12–19
Beck-Schimmer B, Breitenstein S, Bonvini JM, Lesurtel M, Ganter M, Weber A et al (2012) Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial. Ann Surg 256(5):837–844 (discission 844–5)
Arnaud C, Braunersreuther V, Mach F (2005) Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med 15(6):202–206
Hao P-P, Chen Y-G, Wang J-L, Ji W-Q, Xue L, Liu X-H et al (2010) Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease. Clin Exp Pharmacol Physiol 37(4):496–500
Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G et al (2007) Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 49(12):1272–1278
Cámara-Lemarroy CR, Guzmán-de la Garza FJ, Alarcón-Galván G, Cordero-Pérez P, Muñoz-Espinosa L, Torres-González L et al (2014) Hepatic ischemia/reperfusion injury is diminished by atorvastatin in Wistar rats. Arch Med Res 45(3):210–216
Gueler F, Park J-K, Rong S, Kirsch T, Lindschau C, Zheng W et al (2007) Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol 170(4):1192–1199
Dibazar F, Hajipour B, Hosseinian MM, Hemmati MR, Ghandiha A (2008) Simvastatin decreases hepatic ischaemia/reperfusion-induced liver and lung injury in rats. Folia Morphol Warsz 67(4):231–235
Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD et al (1999) Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104(11):1631–1639
Aldrighetti L, Pulitanò C, Arru M, Finazzi R, Catena M, Soldini L et al (2006) Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl 12(6):941–949
Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J et al (2012) Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. J Gastroenterol Hepatol 27(8):1353–1361
Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR (2008) Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg 143(3):247–253 (discussion 253)
Trocha M, Merwid-Lad A, Szuba A, Chlebda E, Pieśniewska M, Sozański T et al (2010) Effect of simvastatin on nitric oxide synthases (eNOS, iNOS) and arginine and its derivatives (ADMA, SDMA) in ischemia/reperfusion injury in rat liver. Pharmacol Rep 62(2):343–351
Lai I-R, Chang K-J, Tsai H-W, Chen C-F (2008) Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction. Transplantation 85(5):732–738
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Sarin, S., Kaman, L., Dahiya, D. et al. Effects of preoperative statin on liver reperfusion injury in major hepatic resection: a pilot study. Updates Surg 68, 191–197 (2016). https://doi.org/10.1007/s13304-016-0370-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-016-0370-3